Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04210557 · ClinicalTrials.gov registry record · NA

Models of Auditory Hallucination

A NA study, sponsored by Yale University.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT04210557 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04210557, a NA study, was terminated before completion, sponsored by Yale University.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

The purpose of this study is to address the shortcoming in clinical hallucination research by causally manipulating the neural loci of conditioned hallucination task behavior in-person in patients with psychosis using transcranial magnetic stimulation (TMS), tracking the impact of this manipulation on the number of times participants with hallucinations report hearing tones that were not presented. With such a causal intervention, the veracity of this explanation of hallucinations will be either validated or disconfirmed. If validated, the task can be further developed as a biomarker for predicting the hallucination onset, guiding, developing or tracking the effects of treatments for hallucinations.

Interventions

  • DEVICE Transcranial Magnetic Stimulation (TMS)

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2020-02-27
Est. Completion 2021-04-01
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04210557

The ClinicalTrials.gov registry entry for NCT04210557 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.

NCT04210557 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04210557 about?

NCT04210557 is a clinical study titled "Models of Auditory Hallucination". The purpose of this study is to address the shortcoming in clinical hallucination research by causally manipulating the neural loci of conditioned hallucination task behavior in-person in patients with psychosis using transcranial magnetic stimulation (TMS), tracking the impact of this manipulation ...

What is the current status of trial NCT04210557?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2020-02-27. Estimated completion is 2021-04-01.

What interventions are being tested in trial NCT04210557?

The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).

Who is sponsoring clinical trial NCT04210557?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.